A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

ClinicalTrials.gov ID: NCT07361510

Public ClinicalTrials.gov record NCT07361510. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Sep 5, 2026, 12:51 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

ROSETTA Lung-202: A Randomized, Double-Blind, Phase 3 Study of Pumitamig Monotherapy Compared to Pembrolizumab as First-line Treatment in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With PD-L1 ≥ 50%.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy of Pumitamig versus Pembrolizumab in participants with previously untreated advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%.

Study identification

NCT ID: NCT07361510
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 3
Lead sponsor: Bristol-Myers Squibb; Industry
Enrollment: 750 participants

Conditions and interventions

Conditions

Non-Small Cell Lung Cancer (NSCLC)

Interventions

Pumitamig Drug
Pembrolizumab Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Mar 11, 2026
Primary completion: Oct 13, 2031
Completion: Oct 13, 2031
Last update posted: Aug 9, 2026

2026 – 2031

United States locations

U.S. sites: 41
U.S. states: 19
U.S. cities: 40

Facility	City	State	ZIP	Site status
Southern Cancer Center Pc	Daphne	Alabama	36526	Recruiting
Mohtaseb Cancer Center & Blood Disorders	Bullhead City	Arizona	86442	Recruiting
Palo Verde Hematology Oncology	Glendale	Arizona	85304	Recruiting
Local Institution - 0407	Anaheim	California	92801	Not yet recruiting
Local Institution - 0352	Beverly Hills	California	90211	Not yet recruiting
Orange Coast Memorial Medical Center	Fountain Valley	California	92708	Recruiting
Local Institution - 0027	Los Alamitos	California	90720	Not yet recruiting
Local Institution - 0422	Los Angeles	California	90095	Not yet recruiting
Local Institution - 0403	Oakland	California	94611	Not yet recruiting
Local Institution - 0208	Pleasant Hill	California	94523	Not yet recruiting
BASS Cancer Center	Walnut Creek	California	94598	Recruiting
Local Institution - 0340	Lakewood	Colorado	80401	Not yet recruiting
Clermont Oncology Center	Clermont	Florida	34711	Recruiting
Advanced Research	Coral Springs	Florida	33321	Recruiting
BRP- Hialeah Hospital	Hialeah	Florida	33013	Recruiting
Florida Clinical Trials Group	Tamarac	Florida	33321	Recruiting
University Cancer & Blood Center, LLC	Athens	Georgia	30607	Recruiting
Local Institution - 0412	Augusta	Georgia	30912	Not yet recruiting
Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital	Marietta	Georgia	30060	Recruiting
Local Institution - 0423	Urbana	Illinois	61801	Not yet recruiting
Northwest Cancer Centers, P.C.	Dyer	Indiana	46311	Recruiting
Missouri Cancer Associates	Columbia	Missouri	65201	Recruiting
Local Institution - 0224	Laurelton	New York	11413	Not yet recruiting
Memorial Sloan Kettering Cancer Center	New York	New York	10065	Recruiting
Optum Medical Care, PC	Westbury	New York	11590	Recruiting
Local Institution - 0283	Winston-Salem	North Carolina	27103	Not yet recruiting
Local Institution - 0383	Cincinnati	Ohio	45220	Not yet recruiting
Local Institution - 0418	Oklahoma City	Oklahoma	73109	Not yet recruiting
Lancaster General Hospital	Lancaster	Pennsylvania	17602	Recruiting
Local Institution - 0028	Pittsburgh	Pennsylvania	15212	Not yet recruiting
WellSpan Oncology Research	York	Pennsylvania	17403	Recruiting
University Of Texas Medical Branch At Galveston	Galveston	Texas	77555	Recruiting
Kelsey-Seybold Clinic Main Campus	Houston	Texas	77025	Recruiting
Texas Oncology - San Antonio	San Antonio	Texas	78217	Recruiting
Local Institution - 0381	San Antonio	Texas	78260	Not yet recruiting
Local Institution - 0337	Richmond	Virginia	23298	Not yet recruiting
Shenandoah Oncology, P.C.	Winchester	Virginia	22601	Recruiting
Local Institution - 0384	Spokane	Washington	99218	Not yet recruiting
Local Institution - 0339	Charleston	West Virginia	25304	Not yet recruiting
HSHS St. Vincent Hospital Regional Cancer Center	Green Bay	Wisconsin	54301	Recruiting
Local Institution - 0421	Marshfield	Wisconsin	54449	Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 237 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07361510, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Aug 9, 2026 · Synced Sep 5, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07361510 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →